EP 4392052 A1 20240703 - COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE
Title (en)
COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG UND PRÄVENTION VON LUNGENERKRANKUNGEN
Title (fr)
COMPOSITIONS ET MÉTHODES DE TRAITEMENT ET DE PRÉVENTION D'UNE MALADIE PULMONAIRE
Publication
Application
Priority
- US 202117409642 A 20210823
- US 2022075356 W 20220823
Abstract (en)
[origin: CA3175945A1] Provided herein are compositions and methods for treating and preventing lung disease. In particular, provided herein are SP-A peptides and uses thereof in the treatment and prevention of lung disease (e.g., asthma or COPD). The compositions may comprise peptides having an amino acid sequence of KEQCVE (SEQ ID NO: 9). The peptide compositions may also be used to treat COVID-19.
IPC 8 full level
A61K 38/17 (2006.01); A61K 9/00 (2006.01); A61P 11/00 (2006.01); C07K 4/00 (2006.01); C07K 7/00 (2006.01); C07K 7/06 (2006.01); C07K 14/00 (2006.01)
CPC (source: EP KR)
A61K 38/08 (2013.01 - KR); A61K 38/10 (2013.01 - KR); A61K 38/17 (2013.01 - KR); A61K 45/06 (2013.01 - KR); A61P 11/00 (2018.01 - EP KR); A61P 11/06 (2018.01 - KR); A61P 31/14 (2018.01 - KR); C07K 14/785 (2013.01 - EP KR); A61K 38/00 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
AU 2022332283 A1 20240307; CA 3175945 A1 20230223; CN 118076372 A 20240524; EP 4392052 A1 20240703; KR 20240052799 A 20240423
DOCDB simple family (application)
AU 2022332283 A 20220823; CA 3175945 A 20220823; CN 202280061457 A 20220823; EP 22862231 A 20220823; KR 20247009792 A 20220823